ABBV vs ORMP
AbbVie Inc (ABBV) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the ABBV and ORMP stock pages for the full models.
Not investment advice.